AMERICAN CENTURY COMPANIES INC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 748054 KANSAS CITY, MO

Position in AUPH

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,034,056

+$621,259 QoQ

Shares Held

355,572

-2.6% QoQ

Ownership

0.267%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 280 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. AUPH ranks #53 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,034,056	355,572	-2.6%	Shares	Defined	2026-08-12
2026-03-31	$5,412,797	365,236	-9.4%	Shares	Defined	2026-05-15
2025-12-31	$6,426,653	402,925	+31.1%	Shares	Defined	2026-02-13
2025-09-30	$3,397,212	307,440	+14.1%	Shares	Defined	2025-11-12
2025-06-30	$2,283,207	269,564	+17.3%	Shares	Defined	2025-08-12
2025-03-31	$1,847,061	229,734	+33.9%	Shares	Defined	2025-05-13
2024-12-31	$1,540,878	171,590	+124.2%	Shares	Defined	2025-02-11
2024-09-30	$560,920	76,524	+208.5%	Shares	Defined	2024-11-12
2023-06-30	$240,131	24,807	0.0%	Shares	Defined	2023-08-14
2023-03-31	$271,884	24,807	—	Shares	Defined	2023-05-11
No filing history on record for this holder in this stock.